SEC Form 4 · accession 0001445064-15-000109
Keenova Therapeutics plc
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Meredith B Fischer
Officer — Sr. VP, Comm & Public Affairs
Period of report
Aug 21, 2015
Accepted (ET)
Aug 24, 2015 · 7:06 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001567892
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Aug 21, 2015 | P | 224 | $89.02 | A | 12,080 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price represents a weighted average. The shares were purchased in multiple transactions at prices ranging from $89.01 to $89.02, inclusive. Ms. Fischer will provide, upon request of the SEC staff, Mallinckrodt plc or a shareholder of Mallinckrodt plc complete information regarding the number of shares purchased at each price within the range.